Johnson & Johnson is buying privately held Auris Health Inc. for $3.4 billion. Auris makes a robotic scope used in respiratory and lung cancer procedures and will allow J&J to gain access to devices that simplify difficult surgical procedures. “This acquisition will accelerate Johnson & Johnson’s entry into robotics with potential for growth and expansion into other interventional applications,” J&J said in a statement.
J&J also said the acquisition would complement its purchase last year of Orthotaxy, a privately held developer of software-enabled robotic technology for surgery.